Dr. Morie Gertz from the Mayo Clinic Rochester, talks about the multiple myeloma clinical trials and abstracts presented at the annual American Society of Clinical Oncologists (ASCO) meeting in Chicago, IL.


Dr. Morie Gertz is a Hematologist/Oncologist and Chair of General Internal Medicine at the Mayo Clinic in Rochester, Minnesota. He treats both amyloidosis and multiple myeloma. View Dr. Morie Gertz’s full biography here.

Previous Post
Living Well with Myeloma: What You Need to Know to Overcome Side Effects from Novel Therapies
Next Post
ASCO 2016: Pembrolizumab in combination with Lenalidomide and Low-Dose Dexamethasone for RRMM

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.